GW Pharmaceuticals PLC Total Voting Rights (8957N)
31 Ottobre 2016 - 3:59PM
UK Regulatory
TIDMGWP
RNS Number : 8957N
GW Pharmaceuticals PLC
31 October 2016
GW Pharmaceuticals PLC ("GW Pharmaceuticals")
TOTAL ISSUED SHARE CAPITAL
Cambridge, UK, 31 October 2016: In accordance with the
requirements of the FCA's Disclosure and Transparency Rule 5.6.1,
GW Pharmaceuticals plc ("GW" or "the Company") (AIM:GWP,
NASDAQ:GWPH) confirms that the Company's issued share capital
consists of 302,458,090 ordinary shares of 0.1p each in issue, each
with equal voting rights. No shares are held in treasury.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine whether they are
required to notify their interest, or a change to their interest,
in the Company under the FCA's Disclosure and Transparency
Rules.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser)
James Steel/Oliver Jackson +44 (0) 20 7418 8900
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRKMMFGDMLGVZM
(END) Dow Jones Newswires
October 31, 2016 10:59 ET (14:59 GMT)
Grafico Azioni Gw Pharmaceuticals (LSE:GWP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Gw Pharmaceuticals (LSE:GWP)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a GW Pharm. (Borsa di Londra): 0 articoli recenti
Più GW Pharm. Articoli Notizie